Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
COVID-19 vaccination efforts continue to progress, after the
December 2020 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Chief Economist, KAR Global.
COVID-19 has hastened the pace of digital transformation in many industries, including auto insurance.
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
As 2020 began, a persistent opioid overdose epidemic was near the forefront of a list of national concerns in the United States.
The Sounding Board recently met with Kate Farley-Agee, our Vice President of Network Products at Coventry, and Tammy Bradly, our Vice President of